Severity of kidney disease |
|
632.2 |
<.0001 |
ESRD - on dialysis vs. GFR 30–60 (no dialysis) |
2.29 (2.12, 2.46) |
|
|
GFR<30 (no dialysis) vs. GFR 30–60 (no dialysis) |
1.77 (1.66, 1.90) |
|
|
|
Age, per 5 year increase above 65 |
1.19 (1.17, 1.21) |
390.1 |
<.0001 |
|
NYHA Class |
|
180.3 |
<.0001 |
III vs. I |
1.63 (1.45, 1.83) |
|
|
II vs. I |
1.18 (1.05, 1.32) |
|
|
|
Diabetes mellitus |
1.38 (1.31, 1.45) |
151.7 |
<.0001 |
|
Chronic lung disease |
1.38 (1.31, 1.46) |
131.6 |
<.0001 |
|
Serum sodium, per 5 mEq/L decrease below 140 |
1.28 (1.22, 1.34) |
115.4 |
<.0001 |
|
Atrial fibrillation or flutter |
1.30 (1.23, 1.36) |
95.6 |
<.0001 |
|
Left ventricular ejection fraction, per 5% decrease |
1.10 (1.07, 1.12) |
77.7 |
<.0001 |
|
Systolic blood pressure, per 5 mm Hg decrease below 120 |
1.06 (1.05, 1.08) |
58.7 |
<.0001 |
|
QRS duration, per 10 ms increase up to 120 |
1.07 (1.05, 1.09) |
44.9 |
<.0001 |
|
Nonsustained ventricular tachycardia |
1.21 (1.14, 1.28) |
41.5 |
<.0001 |
|
Ischemic heart disease |
1.24 (1.16, 1.33) |
38.4 |
<.0001 |
|
Medicare or Medicaid, vs. health maintenance organization/commercial/other/none |
1.22 (1.14, 1.31) |
31.2 |
<.0001 |
|
Cerebrovascular disease |
1.17 (1.10, 1.24) |
23.9 |
<.0001 |
|
Non-white race |
1.16 (1.09, 1.24) |
20.2 |
<.0001 |
|
Prior percutaneous coronary intervention |
0.90 (0.85, 0.95) |
15.0 |
0.0001 |
|
Atrioventricular block, any (1st, 2nd, or 3rd degree) vs. none |
1.11 (1.05, 1.17) |
12.3 |
0.0004 |
|
Male sex |
1.08 (1.02, 1.14) |
6.9 |
0.0085 |